Printer Friendly

DNA Sequencing: Emerging Technologies and Applications.

NEW YORK, Aug. 6, 2014 /PRNewswire/ -- announces that a new market research report is available in its catalogue: DNA Sequencing: Emerging Technologies and Applications REPORT HIGHLIGHTS The global market for sequencing products and services reached $3.5 billion in 2012. This market is expected to grow to nearly $4.5 billion in 2013 and nearly 11.7 billion in 2018, a compound annual growth rate (CAGR) of 21.2%. This report provides: An overview of the global market for sequencing products and services. Analyses of global market trends, with data from 2012, estimates for 2013, and projections of compound annual growth rates (CAGRs) through 2018. Quantification of the DNA sequencing markets by product type, platform, customer type,value chain position, analysis type and geography. A look at substantial future growth opportunities for industry participants including consumer and diagnostic sequencing services, bioinformatics, sequence enrichment, benchtop NGS sequencers and consumables, and emerging sequencing instruments. STUDY GOALS AND OBJECTIVES BCC Research's goal for this study is to provide an in-depth analysis of the sequencing industry, an important industry in life sciences with enormous market potential. The approach for analyzing the industry is taken in terms of workflow (e.g., sequencers, sequence capture, informatics) and key applications (e.g., research, applied, services, sample prep, informatics) where sequencing will have market share by 2018.BCC Research examines the markets for sequencing products and services for the years 2012, 2013 and 2018.Special emphasis is placed on the global next-generation sequencing (NGS) diagnostic markets, which are characterized and quantified by disease indication, test complexity, test purpose and geography.Sequencing market segments that provide exciting growth opportunities include benchtop NGS sequencing instruments and consumables; clinical diagnostics (e.g., cancer, rare genetic diseases and prenatal screening); sequencing software; and consumer sequencing services.The report provides a comprehensive discussion of sequencing technologies, market applications, industry structure, important clinical sequencing initiatives, global markets, patent status and companies. The report is designed to aid companies in their strategic planning efforts for accessing sequencing industry opportunities. REASONS FOR DOING THE STUDY The Human Genome Project (HGP) moved DNA sequencing technology to the forefront of life science research as a genetic analysis tool. The HGP relied heavily on Sanger sequencing by capillary electrophoresis to decipher the DNA sequence of the bases in the human genome.The HGP led to significant improvements in the efficiency and costs of DNA sequencing. During this time period, the sequencing industry consolidated, resulting in one dominant company, Applied Biosystems (now Life Technologies).Beginning in 2005, the launch of next-generation sequencing technologies radically changed the structure of the industry and opened up exciting new market applications. The costs of sequencing have rapidly reduced to the point where it is now feasible for complex NGS tests to be priced in the range of other multiplex genetic tests.As a result, opportunities for sequencing products and services are emerging in diverse applications ranging, for example, from clinical diagnostics to direct to consumer genetic testing markets.Clinical value has been shown for many applications, and several launched tests are having good commercial success. This shows that both patients and physicians are recognizing the value of NGS tests. Several molecular genetic tests that have been successful on non-NGS formats will run on NGS platforms in the future.At the same time, payors and insurance companies are beginning to provide coverage for these tests, further enhancing their commercial potential.In direct to consumer genetic testing market, there is an emerging trend to move to sequencing of specific genome regions. Compared with microarrays, sequencing provides more comprehensive information to the consumer. Recent product introductions by Full Genomes Corporation and Family Tree DNA using NGS to sequence the full Y chromosome are examples of this trend.These technical and market factors are driving this market so that it is now timely to examine the sequencing markets. INTENDED AUDIENCE This report fills a gap in market research as it covers the three main sequencing platforms: Sanger sequencing, NGS and 3GS.The report provides a roadmap for understanding where sequencing is likely to be used in the life sciences during the next five years. As such, it is a useful guide for strategic and business planning, as well as for learning about the impact new sequencing technologies will have in the various market segments.This market report will be useful to many companies involved in the direct to consumer, informatics, clinical, genetic testing and sequencing industries. It will be particularly valuable for companies in such industries as life science research tools, NGS instruments, molecular diagnostics, informatics, clinical laboratories, pharmaceutical, biotechnology, microfluidics, lab-on-a-chip and sample preparation. SCOPE AND FORMAT The scope of the report includes sequencing technologies, applications, industries, initiatives, markets, patents and companies. The markets for sequencing products and services are given for the years 2012, 2013 and 2018.This report reviews the main sequencing platforms, and explains why genetic variation is important for many markets, including clinical testing. It then discusses some of the top research initiatives that are contributing to NGS applications. Market driving forces are also discussed.The report covers the sequencing markets by workflow, including sample preparation products; sequencing instruments & consumables; informatics; and sequencing services. It includes the sequencing instrument market by platform: Sanger, NGS and 3GS and by instrument class: low throughput, high-throughput, benchtop, and handheld.The report covers the markets for the main sequencing end use applications, including research (R&D, drug discovery & development, biotech); clinical; consumer; and applied (forensics, microbial genomics, agricultural genomics).A key part of the report covers NGS clinical markets in depth, including by test complexity, indication and test purpose. Test complexity refers to the multiplexing (e.g., the number of genes covered) and coverage (e.g., the extent to which the genome is covered) of the test. Examining the market by test complexity provides valuable insight into which products (e.g., sample preparation, NGS instrument, informatics) will be in demand in the future.The report provides market data and forecasts for NGS diagnostics by specific applications, including those for cancer, rare diseases, common diseases, and pre- and post-natal screening.Specific geographic markets are discussed, including North America, Europe, China, Japan and the rest of the world.Market data covers the years 2012, 2013 and 2018.Industry sectors analyzed in this report include NGS instruments (including market share data for the main instrument companies); NGS target enrichment; 3GS; direct to consumer genetic testing; single cell genomics; NGS-based proteomics; informatics; information technology; clinical laboratory; and the prenatal diagnostics (including market shares for the leading NGS companies).More than 142 companies in the sequencing industry are profiled in this report.BCC Research provides a summary of the main industry acquisitions and strategic alliances from 2011 through 2013, including key alliance trends. METHODOLOGY Both primary and secondary research methodologies were used in preparing this study. BCC Research examined each of the key end-user market segments that will be commercially important during the next five years.Based on this analysis, the current and future applications of sequencing technologies are evaluated in each of the major market segments and sales revenues are forecast for 2013 through 2018.Based on analysis of both secondary and primary market sources, as well as the key trends in the industry, the report provides the current and projected market size for the various sequencing market segments for the years 2012, 2013 and 2018. Chapter- 1: INTRODUCTION STUDY GOALS AND OBJECTIVES REASONS FOR DOING THE STUDY INTENDED AUDIENCE SCOPE AND FORMAT METHODOLOGY INFORMATION SOURCES RELATED BCC RESEARCH REPORTS ANALYST CREDENTIALS BCC RESEARCH ONLINE SERVICES DISCLAIMER Chapter- 2: EXECUTIVE SUMMARY Table Summary : GLOBAL VALUE OF SEQUENCING PRODUCTS AND SERVICES, BY TYPE, THROUGH 2018 Figure Summary : GLOBAL VALUE OF SEQUENCING PRODUCTS AND SERVICES, BY TYPE, 2012-2018 Chapter- 3: OVERVIEW INTRODUCTION SEQUENCING MARKET SEQUENCING PRODUCTS SEQUENCING PRODUCT LIFE CYCLE STATUS NEXT-GENERATION SEQUENCING INDUSTRY Chapter- 4: TECHNOLOGIES IMPORTANCE OF DNA GENETIC VARIATION AND ANALYSIS GENETIC ANALYSIS TECHNOLOGIES SEQUENCING IN CLINICAL APPLICATIONS SEQUENCING TECHNOLOGIES INFORMATICS TECHNOLOGIES CLINICAL SEQUENCING TECHNOLOGY CHALLENGES TOP TEN CLINICAL NEXT-GENERATION SEQUENCING INITIATIVES Chapter- 5: DNA SEQUENCING APPLICATIONS INTRODUCTION GENETIC ANALYSIS DE NOVO WHOLE GENOME SEQUENCING RESEQUENCING SEQ-BASED METHODS STRUCTURAL VARIATION STUDIES COMPLEMENTARY SEQUENCING AND MICROARRAY PLATFORMS SEQUENCING END-USE APPLICATIONS Chapter- 6: CLINICAL NEXT-GENERATION SEQUENCING APPLICATIONS INTRODUCTION CANCER APPLICATIONS MENDELIAN DISORDERS APPLICATIONS SCREENING APPLICATIONS INFECTIOUS DISEASE APPLICATIONS COMMON DISORDERS APPLICATIONS Chapter- 7: SEQUENCING INDUSTRY INTRODUCTION NEXT-GENERATION SEQUENCING INSTRUMENT INDUSTRY NEXT-GENERATION SEQUENCING TARGET ENRICHMENT INDUSTRY THIRD GENERATION SEQUENCING INDUSTRY DIRECT-TO-CONSUMER GENETIC TESTING INDUSTRY SINGLE CELL GENOMICS INDUSTRY NGS-BASED PROTEOMICS INDUSTRY SEQUENCING INFORMATICS INDUSTRY SEQUENCING INFORMATION TECHNOLOGY INDUSTRY CLINICAL LABORATORY INDUSTRY PRENATAL DIAGNOSTICS INDUSTRY SEQUENCING INDUSTRY ACQUISITIONS AND STRATEGIC ALLIANCES Chapter- 8: SEQUENCING MARKETS GROWTH DRIVING FORCES SEQUENCING MARKET SUMMARY SEQUENCING INSTRUMENTS AND CONSUMABLES MARKET SEQUENCING SAMPLE PREP MARKETS SEQUENCING INFORMATICS MARKET SEQUENCING SERVICES MARKETS CLINICAL NGS MARKET CLINICAL NGS CANCER MARKETS CLINICAL NGS CARDIOVASCULAR MARKETS CLINICAL NGS MENDELIAN DISORDERS MARKETS CLINICAL NGS METABOLIC AND IMMUNE DISORDERS MARKETS CLINICAL NGS NEUROLOGY MARKETS CLINICAL NGS NEWBORN SCREENING MARKETS CLINICAL NGS PRENATAL DIAGNOSTIC MARKETS CLINICAL NGS FOOD-BORNE ILLNESS MARKETS CLINICAL NGS HUMAN LEUKOCYTE ANTIGEN TYPING MARKETS SEQUENCING MARKETS BY GEOGRAPHIC REGION CLINICAL NGS GEOGRAPHICAL MARKETS Chapter- 9: CLINICAL NGS PATENTS CLINICAL NEXT-GENERATION SEQUENCING PATENTS BY INDICATION CLINICAL NEXT-GENERATION SEQUENCING PATENT ISSUES Table 127 : CLINICAL NEXT-GENERATION SEQUENCING PATENTS*, 2002-2012 Chapter- 10: COMPANY PROFILES 23ANDME INC. ADAPTIVE BIOTECHNOLOGIES INC. AGILENT TECHNOLOGIES INC. ALMAC GROUP LTD. AMBRY GENETICS APPISTRY INC. ASSURERX HEALTH ASTRID BIOSCIENCE GMBH ASURAGEN INC. AVIIR INC. BASE4 INNOVATION LTD. BECKMAN COULTER BERRY GENOMICS CO. LTD. BGI BINA TECHNOLOGIES INC. BLUEPRINT GENETICS BOREAL GENOMICS CAMBRIDGE EPIGENETIX LTD. CARIS LIFE SCIENCES CEGAT GMBH CHRONIX BIOMEDICAL CLC BIO CODIFIED GENOMICS LLC CORIELL LIFE SCIENCES INC. CORRELAGEN DIAGNOSTICS INC COUNSYL INC COURTAGEN LIFE SCIENCES INC CYNVENIO BIOSYSTEMS INC CYPHER GENOMICS INC. DIOGENIX INC. DNA ELECTRONICS LTD. DNA LINK DNANEXUS INC. EAGLE GENOMICS, LTD. ELECTRONIC BIOSCIENCES ENZYMATICS INC. EUROFINS MWG OPERON EXIQON A/S EXOSOME DIAGNOSTICS INC. EXPRESSION ANALYSIS INC. FOUNDATION MEDICINE FULL GENOMES CORPORATION GATC BIOTECH AG GE HEALTHCARE GENAPSYS GENDX BV GENE BY GENE LTD. GENEDX INC. GENEPEEKS INC. GENEWIZ INC. GENIA TECHNOLOGIES INC. GENOLOGICS LIFE SCIENCES SOFTWARE GENOMATIX SOFTWARE GMBH GENOMEQUEST INC. GENOMIC HEALTH INC. GIGAGEN INC. GNUBIO INC. GOOD START GENETICS INC. ILLUMINA INC. INGENUITY SYSTEMS INC. INNOVATIONS EXCHANGE PTE LTD INVITAE, INC. IREPERTOIRE KAILOS GENETICS KELLBENX INC. KNOME INC. LABORATORY CORPORATION OF AMERICA INC. LABORATORY FOR MOLECULAR MEDICINE LASERGEN INC. LIFE TECHNOLOGIES INC. MACROGEN INC. MAVERIX BIOMICS INC. MD ANDERSON CANCER CENTER MEDGENOME LABS PVT. LTD. MEDOMICS LLC. MIINOME INC. MULTIPLICOM NV MYRIAD GENETICS INC. NABSYS INC. NATERA INC. NEWGENE LTD. NOBLEGEN BIOSCIENCES N-OF-ONE INC. NOVARTIS AG NUMERATE INC. NXT-DX OMICIA INC. OMIXON BIOCOMPUTING KFT ONCODNA SA ONCOSPIRE GENOMICS OXFORD GENE TECHNOLOGY OXFORD NANOPORE TECHNOLOGIES PACIFIC BIOSCIENCES OF CALIFORNIA INC. PARABASE GENOMICS PASTEL BIOSCIENCE LTD PATHOGENETIX PATHOGENICA PATHOQUEST SAS PERKIN ELMER INC. PERSONAL GENOME DIAGNOSTICS INC. PERSONALIS INC. PICOSEQ POPULATION GENETICS TECHNOLOGIES LTD. PORTABLE GENOMICS LLC PREVENTIONGENETICS INC. QIAGEN QUANTUMDX RAINDANCE TECHNOLOGIES INC. REAL TIME GENOMICS INC. REPROGENETICS RESPONSE GENETICS INC. ROCHE HOLDING AG SCIGENOM LABS SENGENICS INTERNATIONAL PTE LTD. SEQUENOM INC. SEQUENTA INC. SEQUOIA GENETICS CO. LTD. SEVEN BRIDGES GENOMICS INC. SIEMENS AG SILICON VALLEY BIOSYSTEMS SINGLE CELL TECHNOLOGY, INC. SISTEMAS GENOMICOS SOFTGENETICS LLC SPIRAL GENETICS INC. STATION X INC. STRAND LIFE SCIENCES STRATOS GENOMICS INC. SUNDANCE DIAGNOSTICS INC. SYAPSE SYGNIS AG SYNAPDX THERMO FISHER SCIENTIFIC INC. TRANSGENOMIC INC. TROVAGENE INC. TUTE GENOMICS, INC. TWO PORE GUYS INC. WARP DRIVE BIO LLC YIKON GENOMICS CO. LTD. ZS GENETICS ZYMO RESEARCH CORPORATION To order this report: DNA Sequencing: Emerging Technologies and Applications __________________________ Contact Clare: US: (339)-368-6001 Intl: +1 339-368-6001

SOURCE Reportlinker
COPYRIGHT 2014 PR Newswire Association LLC
No portion of this article can be reproduced without the express written permission from the copyright holder.
Copyright 2014 Gale, Cengage Learning. All rights reserved.

Article Details
Printer friendly Cite/link Email Feedback
Publication:PR Newswire
Date:Aug 6, 2014
Previous Article:Relmada Therapeutics, Inc. Completes Name Change and Announces New Ticker.
Next Article:PA Lottery Cash 5 Ticket Worth $325,000 Sold in Dauphin County.

Terms of use | Copyright © 2017 Farlex, Inc. | Feedback | For webmasters